Holen Sie sich die Stockscreener-App
21.64
0.05%
0.01
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
Pharmaceutical Stocks To Watch TodayFebruary 12th - MarketBeat
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - BioSpace
Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market - TradingView
Alkermes Acquires Avadel Pharmaceuticals - Contract Pharma
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Alkermes Completes Acquisition and Delisting of Avadel Pharmaceuticals - TipRanks
Avadel Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Alkermes (Nasdaq: ALKS) closes Avadel acquisition, adds LUMRYZ and $1.5B loans - Stock Titan
(AVDL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Growth Recap: Is Avadel Pharmaceuticals plc stock a falling knife or bargain buyQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Form 8.3 -Avadel Pharmaceuticals plc - The Manila Times
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes - TipRanks
Alkermes (ALKS) Set to Finalize Acquisition of Avadel Pharmaceuticals - GuruFocus
Avadel Pharmaceuticals plc Announces High Court Approval of Scheme of Arrangement for Acquisition by Alkermes plc - Quiver Quantitative
Avadel Pharmaceuticals Announces Outcome of the Court Sanction Hearing - The Manila Times
Irish court clears Alkermes buyout; Avadel stock trading ends Feb. 11 - Stock Titan
Alkermes Increases Offer for Avadel Acquisition - MSN
Penserra Capital Management LLC Buys New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Goldman Sachs (EPT)Form 38.5b- AVADEL PHARMACEUTICALS PLC - Research Tree
Market Review: Is Avadel Pharmaceuticals plc vulnerable to short sellersJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Sees Large Increase in Short Interest - MarketBeat
Macro Review: Will CMBT outperform tech stocksEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Responsive Playbooks and the AVDL Inflection - Stock Traders Daily
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Is Avadel Pharmaceuticals plc on track to beat earningsEarnings Beat & Reliable Breakout Forecasts - Mfd.ru
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal - Investing.com Nigeria
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal By Investing.com - Investing.com India
Swing Trade: Will ChargePoint Holdings Inc benefit from seasonalityJuly 2025 Action & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Pass Above 200 Day Moving AverageTime to Sell? - MarketBeat
Understanding the Setup: (AVDL) and Scalable Risk - Stock Traders Daily
Avadel Sets Court Date for Alkermes Acquisition Scheme - TipRanks
Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets
Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan
Avadel Pharmaceuticals appoints Susan Rodriguez as COO - MSN
State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - intellectia.ai
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals (AVDL) Investor Outlook: Navigating a 54.90% Revenue Growth Amidst a Hold-Heavy Consensus - DirectorsTalk Interviews
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India
0.63%
10.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):